Gottlieb Boasts Record Generic Approvals; AAM Says Not Enough

FDA approved more generics in the month of October than in any previous month, FDA Commissioner Scott Gottlieb said in a statement Friday. The generic drug lobby repeated its past stance that approving more generics alone is not enough to lower drug prices. “We’ll continue our efforts to increase competition and help lower costs for patients with our Drug Competition Action Plan and will do so by continuing to advance policies that increase the efficiency of our generic drug program...